| Bioactivity | Cbl-b-IN-12 (Example 10) is a casitas B-lineage lymphoma-b (CBL-B) inhibitor with an IC50 of <100 nM[1]. |
| Target | IC50: <100 nM (CBL-B) |
| Name | Cbl-b-IN-12 |
| CAS | 2851871-29-7 |
| Formula | C28H29F3N6O2 |
| Molar Mass | 538.56 |
| Transport | Room temperature in continental US; may vary elsewhere. |
| Storage | Please store the product under the recommended conditions in the Certificate of Analysis. |
| Reference | [1]. Yingzhi Bi, et al. Compounds, compositions and methods of treating cancer. Patent WO2022221704A1. |